NCT01026220 · OUTCOME

Relapse-free Survival

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: Probability of survival
Interval / dispersion: 95% Confidence Interval
Time frame: 3 years from enrollment

What was measured

A description, survival to relapse, of patterns of relapse after Doxorubicin, Bleomycin, Vincristine, Etoposide - Prednisone, Cyclophosphamide (ABVE-PC) and risk-adapted radiotherapy.

Analysis population: 161 patients began consolidation therapy: 126 patients received risk-adapted radiotherapy after consolidation therapy ABVE-PC and 35 did not.

Groups in this outcome

Group 1

All Patients

Group 6

risk-adapted radiation therapy

Group 7

no risk-adapted radiation therapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Group 1	161
Group 6	126
Group 7	35

Reported measurements

Source class 1

Values in Probability of survival · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
Group 1	0.82	Not reported	0.75	0.87	Not reported
Group 6	0.83	Not reported	0.75	0.88	Not reported
Group 7	0.79	Not reported	0.60	0.89	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
0.75
upper Limit
0.87
value
0.82
group Id
OG001
lower Limit
0.75
upper Limit
0.88
value
0.83
group Id
OG002
lower Limit
0.60
upper Limit
0.89
value
0.79

denoms

counts
group Id
OG000
value
161
group Id
OG001
value
126
group Id
OG002
value
35
units
Participants

description

A description, survival to relapse, of patterns of relapse after Doxorubicin, Bleomycin, Vincristine, Etoposide - Prednisone, Cyclophosphamide (ABVE-PC) and risk-adapted radiotherapy.

dispersion Type

95% Confidence Interval

groups

description
All Patients
id
OG000
title
Group 1
description
risk-adapted radiation therapy
id
OG001
title
Group 6
description
no risk-adapted radiation therapy
id
OG002
title
Group 7

param Type

NUMBER

population Description

161 patients began consolidation therapy: 126 patients received risk-adapted radiotherapy after consolidation therapy ABVE-PC and 35 did not.

reporting Status

POSTED

time Frame

3 years from enrollment

title

Relapse-free Survival

type

SECONDARY

unit Of Measure

Probability of survival

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice